tricaprin
Term · Oncology and biomedicine · MLC-T-ONC-017317
An orally available precursor of decanoic acid (DA), a 10-carbon fatty acid and major component of medium chain triglyceride oils, with potential antiandrogen and antihyperglycemic properties. Upon oral administration, tricaprin is hydrolyzed to DA, which binds to and partially activates peroxisome proliferator-activated receptor (PPAR)-gamma, as well as PPAR-alpha and PPAR-beta/delta, without inducing adipogenesis. Additionally, tricaprin may improve insulin sensitivity and decrease androgen production.
| Identifier | MLC-T-ONC-017317 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | glycerol tridecanoate; tridecanoin; tricapric glyceride; glycerol tricaprin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017317",
"term": "tricaprin",
"field": "Oncology and biomedicine",
"definition": "An orally available precursor of decanoic acid (DA), a 10-carbon fatty acid and major component of medium chain triglyceride oils, with potential antiandrogen and antihyperglycemic properties. Upon oral administration, tricaprin is hydrolyzed to DA, which binds to and partially activates peroxisome proliferator-activated receptor (PPAR)-gamma, as well as PPAR-alpha and PPAR-beta/delta, without inducing adipogenesis. Additionally, tricaprin may improve insulin sensitivity and decrease androgen production.",
"synonyms": [
"glycerol tridecanoate",
"tridecanoin",
"tricapric glyceride",
"glycerol tricaprin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tricaprin/"
}
Record 16,705 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.